Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Yayoi Nishida"'
Autor:
Yayoi Nishida, Yasuo Takahashi, Kotoe Tezuka, Hayato Akimoto, Tomohiro Nakayama, Satoshi Asai
Publikováno v:
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-12 (2020)
Abstract Background The purpose of this study was to evaluate and compare the effects on laboratory parameters among monotherapy with five DPP-4 inhibitors in patients with type 2 diabetes mellitus (DM). Methods We identified cohorts of new sitaglipt
Externí odkaz:
https://doaj.org/article/f1fda519f974406e93aa03240f52f7d1
Autor:
Keiko Yamazaki, Yasuo Takahashi, Kotoe Teduka, Tomohiro Nakayama, Yayoi Nishida, Satoshi Asai
Publikováno v:
BMC Pharmacology and Toxicology, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background The aim of this study was to investigate the association between statin use and new-onset diabetes in clinical settings and to assess its effect modification (heterogeneity) among patients with various medical histories and curren
Externí odkaz:
https://doaj.org/article/db4c9622c2e1437fb9a951156a1a5158
Autor:
Hayato Akimoto, Kotoe Tezuka, Yayoi Nishida, Tomohiro Nakayama, Yasuo Takahashi, Satoshi Asai
Publikováno v:
Pharmacology Research & Perspectives, Vol 7, Iss 6, Pp n/a-n/a (2019)
Abstract Type 2 diabetes mellitus (T2DM) is a risk factor for depression. Since brain insulin resistance plays a potential role in depression, the future risk of depression in patients with T2DM may be altered depending on the class of oral hypoglyce
Externí odkaz:
https://doaj.org/article/bc03e78acd024a7aacb66dd6349d1607
Autor:
Yayoi Nishida1 nishida.yayoi@nihon-u.ac.jp, Yasuo Takahashi1,2 takahashi.yasuo@nihon-u.ac.jp, Kotoe Tezuka1 teduka.kotoe@nihon-u.ac.jp, Satoshi Takeuchi3 takeuchi.satoshi@nihon-u.ac.jp, Tomohiro Nakayama2,4 nakayama.tomohiro@nihon-u.ac.jp, Satoshi Asai3 asai.satoshi@nihon-u.ac.jp
Publikováno v:
Drugs in R&D. Sep2017, Vol. 17 Issue 3, p403-412. 10p.
Autor:
Yayoi Nishida1, Yasuo Takahashi1 takahashi.yasuo@nihon-u.ac.jp, Kotoe Tezuka1, Satoshi Takeuchi2, Tomohiro Nakayama3,4, Satoshi Asai2
Publikováno v:
Cardiology & Therapy. Jun2017, Vol. 6 Issue 1, p69-80. 12p.
Publikováno v:
Journal of Pharmacological Sciences, Vol 106, Iss 4, Pp 663-666 (2008)
The present study examined the levels of Angiotensin II type 1 receptor (AT1) and type 2 receptor (AT2) in the brain stem and cerebral cortex of the stroke-prone spontaneously hypertensive rat (SHR-sp) after long-term treatment with three types of an
Externí odkaz:
https://doaj.org/article/a88d9015597041eab9c01814b4a504b7
Publikováno v:
Endocrine journal. 69(4)
The burden of disease of X-linked hypophosphatemia (XLH) in East Asia is poorly understood. This was a cross-sectional study using an online questionnaire to evaluate health-related quality of life (HRQOL) and disease complications in Japanese and Ko
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42ab34f5394fcd21d5b99cd217ac7ede
https://pubmed.ncbi.nlm.nih.gov/34732603
https://pubmed.ncbi.nlm.nih.gov/34732603
Publikováno v:
Journal of Pharmacological Sciences, Vol 97, Iss 1, Pp 153-156 (2005)
We investigated the expression of 50 cytochrome P450 (CYP) genes in the post-ischemic reperfused rat liver using a DNA microarray. Thirteen CYPs showed absent expression in all experiments and 2 CYPs were induced by pentobarbital, which was used as a
Externí odkaz:
https://doaj.org/article/2e7565bbdf4546ed9a3e94b45bc80100
Autor:
Hayato Akimoto, Satoshi Asai, Tomohiro Nakayama, Kotoe Tezuka, Yayoi Nishida, Yasuo Takahashi
Publikováno v:
BMC Pharmacology & Toxicology
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-12 (2020)
BMC Pharmacology and Toxicology, Vol 21, Iss 1, Pp 1-12 (2020)
Background The purpose of this study was to evaluate and compare the effects on laboratory parameters among monotherapy with five DPP-4 inhibitors in patients with type 2 diabetes mellitus (DM). Methods We identified cohorts of new sitagliptin users
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5609abdbbc6b05ccd6d72812150d3102
http://europepmc.org/articles/PMC7171729
http://europepmc.org/articles/PMC7171729
Autor:
Tomohiro Nakayama, Hayato Akimoto, Yasuo Takahashi, Kotoe Tezuka, Yayoi Nishida, Satoshi Asai
Publikováno v:
Pharmacology Research & Perspectives, Vol 7, Iss 6, Pp n/a-n/a (2019)
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives
Type 2 diabetes mellitus (T2DM) is a risk factor for depression. Since brain insulin resistance plays a potential role in depression, the future risk of depression in patients with T2DM may be altered depending on the class of oral hypoglycemic agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2423c993d8ac287d76e1e32e251bf5eb
https://doaj.org/article/bc03e78acd024a7aacb66dd6349d1607
https://doaj.org/article/bc03e78acd024a7aacb66dd6349d1607